Effects of cytotoxic agents on functional integrity and antioxidant enzymes in clonal beta-cells

Diabetes and Metabolism

Volumn 28, Issue 6 II, 2002, Pages

  Picton, S F ^a   McCluskey, J T ^a   Flatt, P R ^a   McClenaghan, N H ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Antioxidant enzymes; Cell viability; Clonal pancreatic beta cells

Indexed keywords

ALLOXAN; ANTIOXIDANT; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; NINHYDRIN; RNA; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CELL VIABILITY; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; GENE EXPRESSION; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLOXAN; ANIMALS; APOPTOSIS; CELL LINE; CYTOTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN PEROXIDE; INSULIN; INSULINOMA; ISLETS OF LANGERHANS; KINETICS; NINHYDRIN; PANCREATIC NEOPLASMS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOZOCIN; TUMOR CELLS, CULTURED;

EID: 0036938182     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. McClenaghan NH, Barnett CR, Ah-Sing E, et al. Characterisation of a novel glucose responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion. Diabetes, 1996, 45, 1132-1140.
2. Gunnarsson R, Berne C, Hellerstrom C. Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic β-cells with special regard to the role of nicotinamide-adenine dinucleotide. Biochem J, 1974, 140, 487-494.
3. Drews G, Krämer C, Düfer M, Krippet-Drews P. Contrasting effects of alloxan on islets and single mouse pancreatic β-cells. Biochem J, 2000, 352, 389-397.
4. Lenzen S, Tiedge M, Flatt PR, Bailey CJ, Panten U. Defective regulation of glucokinase in rat pancreatic islet cell tumours. Acta Endocrin, 1987, 115, 514-520.
5. McClenaghan NH, Elsner M, Tiedge M, Lenzen S. Molecular characterization of the glucose-sensing mechanism in the clonal insulin-secreting BRIN-BD11 cell line. Biochem Biophys Res Comm, 1998, 242, 262-266.
6. Maechler P, Jornot L, Wollheim CB. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta-cells. J Biol Chem, 1999, 274, 27905-27913.
7. Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet, 1994, 344, 721-724.
8. Tiedge M, Lortz S, Munday R, Lenzen S. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes, 1998, 47, 1578-1585.
9. Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG. Determinants of the selective toxicity of alloxan to the pancreatic β-cell. Proc Natl Acad Sci USA, 1982, 79, 927-930.
10. Lenzen S, Panten U. Alloxan: history and mechanism of action. Diabetologia, 1988, 31, 337-342.
11. Lenzen S, Brand F-H, Panten U. Structural requirements of alloxan and ninhydrin for glucokinase inhibition and of glucose for protection against inhibition. Brit J Pharmacol, 1998, 95, 851-859.
12. McDaniel ML, Roth CE, Fink CJ, Swanson JA, Lacy PE. Ninhydrin inhibition of glucose-induced insulin release. Diabetologia, 1977, 13, 603-606.
13. Jörns A, Munday R, Tiedge M, Lenzen S. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro. J Endocrinol, 1997, 155, 283-293.
14. Lenzen S, Freytag S, Panten U, Flatt PR, Bailey CJ. Alloxan and ninhydrin inhibition of hexokinase from pancreatic islets and tumoural insulin-secreting cells. Pharmacol Toxicol, 1990, 66, 157-162.
15. Munday R, Ludwig K, Lenzen S. The relationship between the physiochemical properties and the biological effects of alloxan and several N-alkyl substituted alloxan derivatives. J Endocrinol, 1993, 139, 153-163.
16. 2+ transport. Mol Cell Biochem, 1992, 118, 141-151.
17. Bloch KO, Zemel R, Bloch OV, Grief H, Vardi P. Streptozotocin and alloxan-based selection improves toxin resistance of insulin-producing RINm cells. Int J Exp Diabetes Res, 2000, 1, 211-219.
18. Tiedge M, Lortz S, Munday R, Lenzen S. Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia, 1999, 42, 849-855.
19. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia, 2000, 43, 1528-1533.
20. Flatt PR, Shibier O, Ioannides C, Swanston-Flatt SK. Studies on the chemical and immunological destruction of insulin-secreting islet cell tumours. Exp Clin Endocrinol, 1989, 93, 193-202.
21. Sener A, Malaisse-Lagae F, Giroix MH, Malaisse WJ. Sensitivity to pentamidine but resistance to streptozotocin of tumoral insulin-producing cells (RINm5F line). Pancreas, 1986, 1, 550-555.
22. Janjic D, Wollheim CB. Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia, 1992, 35, 482-485.
23. Meade A. Studies on the mechanisms of pancreatic β-cell dysfunction in diabetes. DPhil Thesis, University of Ulster, 1999.
24. Scarabelli TM, Knight RA, Rayment NB, et al. Quantitative assessment of cardiac myocyte apoptosis in tissue sections using the fluorescence-based tunnel technique enhanced with counterstains. J Immun Meth, 1999, 228, 23-28.
25. Brazda E, Flautner L, Harsányi L, Donáth T, Adeghate E. Acridine-orange uptake: new method to evaluate effects of organ preservation on viability of pancreatic grafts in the pig model. Transplantation Proceedings, 1998, 30, 567-568.
26. Okamoto H. Mechanisms of destruction of insulin-secreting cells. In: Flatt PR, ed. Portland Press. London: Nutrient Regulation of Insulin Secretion. 1992, 387-406.
27. Knip M, Akerblom HK. Environmental factors in the pathogenesis of type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes, 1999, 107, 93-100.
28. Disdier-Flores OM, Rodriguez-Lugo LA, Perez-Perdomo R, Perez-Cardona CM. The public health burden of diabetes: a comprehensive review. P R Health Sci J, 2001, 20, 123-130.
29. Saini KS, Thompson C, Winterford CM, Walker NI, Cameron DP. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta-cell line, INS-1. Biochem Mol Biol Int, 1996, 39, 1229-1236.
30. Janjic D, Maechler P, Sekine N, Bartley C, Annen AS, Wolheim CB. Free radical modulation of insulin release in INS-1 cells exposed to alloxan. Biochem Pharmacol, 1999, 57, 639-648.
31. McClenaghan NH, Barnett CR, O'Harte FPM, Flatt PR. Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic cell line. J Endocrin, 1996, 151, 349-357.
32. Rasschaert J, Flatt PR, Barnett CR, McClenaghan NH, Malaisse WJ. D-glucose metabolism in BRIN-ND11 islet cells. Biochem Mol Med, 1996, 57, 97-105.
33. Meglasson MD, Burch PT, Berner DK, Majafi H, Matchinsky FM. Identification of glucokinase as an alloxan-sensitive glucose sensor of the pancreatic β-cell. Diabetes, 1986, 35, 1163-1173.
34. Lenzen S, Freytag S, Panten U. Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme. Mol Pharmacol, 34, 395-400.
35. Lenzen S, Tiedge M, Panten U. Glucokinase in pancreatic β-cells and its inhibition by alloxan. Acta Endocrinol, 1987, 115, 21-29.